Fennec Pharmaceuticals (FENC) Tops Q1 EPS by 48c

Fennec Pharmaceuticals (NASDAQ: FENC) reported Q1 EPS of $0.41, $0.48 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $25.4 million versus the consensus estimate of $10.09 million.

For earnings history and earnings-related data on Fennec Pharmaceuticals (FENC) click here.

You May Also Be Interested In

• Burry doubles down on Nebius short after stock surges 34% on earnings
• Live Ventures (LIVE) Reports Q3 Loss of $0.34
• Ackman adds Netflix, Visa and Mastercard in portfolio revamp